Trial intelligence / Profile preview

CAI and Paclitaxel in Advanced Ovarian Cancer

NCT00001426Phase 2Completed

Sponsor
National Cancer Institute
Start
Feb 1995
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of carboxyamidotriazole in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal carcinoma (PPC), sponsored by National Cancer Institute. Started Feb 1995; status: completed.

02

Drugs

carboxyamidotriazole
03

Conditions

ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)

Beyond the preview

Go deeper on NCT00001426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call